John T. Treace Sells $966K of Treace Medical Concepts Inc (TMCI) — SEC Form 4, Dec 22, 2021

Open-Market Net Sale · SEC Form 4
−$966,440
10b5-1 Plan

Equity position changed by -0.6%

Reporting Owner
John T. Treace
CEO 10% Owner
TXN 2021-12-21 · FILED 2021-12-22
Equity Position 10.9M sh 10,911,709 → 10,851,214
Equity Change -0.6% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

Treace Medical Concepts Inc

TMCI CIK 0001630627
All Treace Medical Concepts Inc insider activity
Filing Date
2021-12-22
Report Date
2021-12-20
Accession No.
0001567619-21-022460
Accepted At
2021-12-23 00:05 UTC
Reporting Owner
Name Relationship
John T. Treace CIK 0001856380
Director CEO 10% Owner
John T. Treace at Treace Medical Concepts Inc Full insider history
Bought (12 mo) $1,351,631
Sold (12 mo) —
More from this insider at Treace Medical Concepts Inc
2026-08-24 Buy +$246,654 View
2026-06-11 Buy +$210,968 View
2026-06-01 Buy +$177,915 View
2026-05-28 Buy +$340,589 View
2026-05-14 Buy +$375,505 View
All filings by this insider at Treace Medical Concepts Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1F2 2021-12-20 S - Sale 10b5-1 22,311 D $15.74 -$351,113 5,565,269 Direct
Common StockF1F3 2021-12-20 S - Sale 10b5-1 600 D $16.31 -$9,784 5,564,669 Direct
Common StockF1F4 2021-12-21 S - Sale 10b5-1 34,047 D $16.09 -$547,649 5,530,622 Direct
Common StockF1F5 2021-12-21 S - Sale 10b5-1 3,537 D $16.37 -$57,894 5,527,085 Direct
Non-Derivative Holdings
Title Shares Held Ownership
Common StockF6 1,605,000 Indirect
Common StockF6 1,471,250 Indirect
Common StockF7 1,839,063 Indirect
Common StockF7 408,816 Indirect
Footnotes (7)
F1
Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Show more
F2
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.205 to $15.935 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Show more
F3
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.24 to $16.32 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Show more
F4
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.32 to $16.31 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Show more
F5
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.32 to $16.45 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Show more
F6
The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee. Show more
F7
The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee. Show more

Related filings at Treace Medical Concepts Inc

Institutional Holders
13F holders · Jun 30, 2026 115 institutional managers reporting a position
Largest by reported value
  1. Armistice Capital, Llc $25.3M
  2. Bank Of America Corporation $13.2M
  3. Gagnon Securities Llc $12.1M
5%+ Holders · 13D/G 4 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Treace Medical Concepts Inc
All Treace Medical Concepts Inc insider activity
GET /v1/forms/4/0001567619-21-022460 API docs
View Original SEC Filing